Literature DB >> 2577954

The neuropeptide head activator loses its biological acitivity by dimerization.

H Bodenmüller1, E Schilling, B Zachmann, H C Schaller.   

Abstract

On molecular sieve columns the neuropeptide head activator elutes at two distinct positions corresponding to apparent mol. wts of 700 and 1400 daltons. The low mol. wt component is stable only under high ionic conditions and represents the monomeric state of the head activator. Only this form is biologically active. The higher mol. wt component, which is reapidly formed under physiological conditions, is the dimeric head activator and is biologically inactive. We suggest that this dimerization is of biological relevance as a mechanism for inactivation of neuropeptides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2577954      PMCID: PMC1167047          DOI: 10.1002/j.1460-2075.1986.tb04433.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  16 in total

1.  Algorithms for prediction of alpha-helical and beta-structural regions in globular proteins.

Authors:  V I Lim
Journal:  J Mol Biol       Date:  1974-10-05       Impact factor: 5.469

2.  Crystal structure of methionine-enkephalin.

Authors:  D Mastropaolo; A Camerman; N Camerman
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

3.  Estimation of globular protein secondary structure from circular dichroism.

Authors:  S W Provencher; J Glöckner
Journal:  Biochemistry       Date:  1981-01-06       Impact factor: 3.162

4.  Enzyme-linked immunosorbent assay for the neuropeptide 'head activator'.

Authors:  H C Schaller; H Bodenmüller; B Zachmann; E Schilling
Journal:  Eur J Biochem       Date:  1984-01-16

5.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

6.  Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans.

Authors:  H Bodenmüller; H C Schaller
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

7.  Somatostatin release and plasma molecular somatostatin components in man.

Authors:  P G Burhol; I Lygren; T G Jenssen; J Florholmen; R Jorde
Journal:  Acta Physiol Scand       Date:  1984-07

8.  Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man.

Authors:  P G Burhol; T G Jenssen; I Lygren; T B Schulz; R Jorde; H L Waldum
Journal:  Digestion       Date:  1982       Impact factor: 3.216

9.  Radioimmunoassay of plasma gastric inhibitory polypeptide (GIP), release of GIP after a test meal and duodenal infusion of bile, and immunoreactive plasma GIP components in man.

Authors:  P G Burhol; R Jorde; H L Waldum
Journal:  Digestion       Date:  1980       Impact factor: 3.216

10.  Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk.

Authors:  R C Baxter; Z Zaltsman; J R Turtle
Journal:  J Clin Endocrinol Metab       Date:  1984-06       Impact factor: 5.958

View more
  6 in total

1.  Development of new peptide-based tools for studying synaptic ribbon function.

Authors:  Adam A Francis; Bhupesh Mehta; David Zenisek
Journal:  J Neurophysiol       Date:  2011-06-08       Impact factor: 2.714

2.  Head activator does not qualitatively alter head morphology in regenerates ofHydra oligactis.

Authors:  Lorette Claire Javois; Victoria Kitale Tombe
Journal:  Rouxs Arch Dev Biol       Date:  1991-07

3.  Brain Membrane Fractionation: An Ex Vivo Approach to Assess Subsynaptic Protein Localization.

Authors:  Xavier Morató; Marc López-Cano; Paula M Canas; Rodrigo A Cunha; Francisco Ciruela
Journal:  J Vis Exp       Date:  2017-05-12       Impact factor: 1.355

4.  Reinvestigation of the proposed folding and self-association of the Neuropeptide Head Activator.

Authors:  Jonathan R Lai; Samuel H Gellman
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

5.  Head activator acts as an autocrine growth factor for NH15-CA2 cells in the G2/mitosis transition.

Authors:  H C Schaller; S Druffel-Augustin; S Dübel
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

6.  The head activator is released from regenerating Hydra bound to a carrier molecule.

Authors:  H C Schaller; M Roberge; B Zachmann; S Hoffmeister; E Schilling; H Bodenmüller
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.